| Nov 7 |
Collegium Pharmaceutical Non-GAAP EPS of $1.61 beats by $0.02, revenue of $159.3M beats by $3.73M
|
| Nov 7 |
Collegium Pharmaceutical: Q3 Earnings Snapshot
|
| Nov 7 |
Collegium names Vikram Karnani as CEO
|
| Nov 7 |
Collegium Reports Record Third Quarter 2024 Financial Results
|
| Nov 7 |
Collegium Appoints Vikram Karnani as Chief Executive Officer
|
| Nov 6 |
Collegium Pharmaceutical Q3 2024 Earnings Preview
|
| Oct 31 |
Collegium Pharmaceutical (COLL) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
|
| Oct 28 |
Collegium Pharmaceutical to Report Q3 Earnings: What's in the Cards?
|
| Oct 24 |
Collegium to Report Third Quarter 2024 Financial Results on November 7, 2024
|
| Oct 11 |
Are Investors Undervaluing Collegium Pharmaceutical (COLL) Right Now?
|
